Cellectis Reports First Quarter 2026 Financial Results
May 12, 2026 - 03:06
Cellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs.
The company is advancing its pivotal Phase 2 trial of lasme-cel in relapsed/refractory B-cell acute lymphoblastic leukemia, known as the BALLI-01 study. The first interim analysis from this trial is expected in the fourth quarter of 2026, with a Biologics License Application submission anticipated in 2028.
In non-Hodgkin lymphoma, Cellectis is running the Phase 1 NATHALI-01 trial with eti-cel. The company expects to report the full Phase 1 dataset in the fourth quarter of 2026.
On the innovation front, Cellectis will present preclinical data on TALE-based epigenetic editing at the upcoming ASGCT meeting. This approach does not involve cutting DNA, representing a potentially safer method for genetic modification.
through its partnership with Servier and Allogene, interim pivotal data from the ALPHA3 trial of cema-cel has been reported. Among 24 patients in the cema-cel treatment arm, 58.3% achieved a complete response.
These developments mark steady progress across Cellectis' pipeline as the company moves toward key regulatory milestones in the coming years.
MORE NEWS
October 14, 2026 - 00:16
Bank of America Slapped with $1.2 Billion Fine for Money Laundering FailuresFederal regulators have imposed a hefty penalty on Bank of America, ordering the financial giant to pay over $1.2 billion for shortcomings in its anti-money laundering controls. The fine, announced...
October 13, 2026 - 02:12
GAC Connects with Europe Through Engineering and Football at 2026 Paris Motor ShowThe 91st Paris Motor Show opened on October 12 at Paris Expo Porte de Versailles, where one Chinese manufacturer made its presence felt with a mix of technology and sport. The company displayed...
October 12, 2026 - 17:30
Sector Update: Financial Stocks Advance Late AfternoonFinancial sector stocks moved higher in the final hours of Monday`s trading session, recovering from a sluggish start to the day. The NYSE Financial Index climbed 0.5%, reflecting renewed buying...
October 12, 2026 - 02:39
Washington Warns Kyiv Over Refinery Strikes As Envoy Pushes European CapitalsAmerican officials have signaled they could cut off a key weapons pipeline to Ukraine if long range strikes on Russian oil infrastructure continue, according to people familiar with the discussions...